메뉴 건너뛰기




Volumn 122, Issue 1, 2010, Pages 5-7

Editorial: Drug-eluting stent restenosis: An uncommon yet pervasive problem

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGIST; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EDITORIAL; HUMAN; MEDICAL RESEARCH; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; EPIDEMIOLOGY; HEART MUSCLE REVASCULARIZATION; NOTE; PATIENT; PSYCHOLOGICAL ASPECT;

EID: 77954621831     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.962423     Document Type: Editorial
Times cited : (22)

References (19)
  • 1
    • 0037425744 scopus 로고    scopus 로고
    • 25 years of coronary angioplasty: Almost a fairy tale
    • Meier B, Bachmann D, Luscher, T. 25 years of coronary angioplasty: almost a fairy tale. The Lancet. 2003;361:527.
    • (2003) The Lancet , vol.361 , pp. 527
    • Meier, B.1    Bachmann, D.2    Luscher, T.3
  • 2
    • 0035843253 scopus 로고    scopus 로고
    • The first patient to undergo coronary angioplasty: 23-year follow-up
    • Meier B. The first patient to undergo coronary angioplasty: 23-year follow-up. N Engl J Med. 2001;344:144-145.
    • (2001) N Engl J Med , vol.344 , pp. 144-145
    • Meier, B.1
  • 3
    • 77953098629 scopus 로고    scopus 로고
    • Randomized trial of paclitaxel-versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) Study
    • for the ISAR-DESIRE 2 Investigators DOI:10.1016/j.jacc.2010.02.009. Available at: Accessed June
    • Mehilli J, Byrne RA, Tiroch K, Pinieck S, Schulz S, Kufner S, Massberg S, Laugwitz KL, Schömig A, Kastrati A; for the ISAR-DESIRE 2 Investigators. Randomized trial of paclitaxel-versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) Study. J Am Coll Cardiol. March 5, 2010. DOI:10.1016/j.jacc.2010.02.009. Available at: http://dx.doi.org/10.1016/j.jacc. 2010.02.009. Accessed June 5, 2010.
    • (2010) J Am Coll Cardiol. March , vol.5 , pp. 2010
    • Mehilli, J.1    Byrne, R.A.2    Tiroch, K.3    Pinieck, S.4    Schulz, S.5    Kufner, S.6    Massberg, S.7    Laugwitz, K.L.8    Schömig, A.9    Kastrati, A.10
  • 6
    • 55849141303 scopus 로고    scopus 로고
    • Treatment of paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: Angiographic and clinical outcomes[in Spanish]
    • Byrne R, Iijima R, Mehilli J, Pache J, Schulz S, Schömig A, Kastrati A. Treatment of paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes[in Spanish]. Rev Esp Cardiol. 2008;61:1134-1139.
    • (2008) Rev Esp Cardiol , vol.61 , pp. 1134-1139
    • Byrne, R.1    Iijima, R.2    Mehilli, J.3    Pache, J.4    Schulz, S.5    Schömig, A.6    Kastrati, A.7
  • 11
    • 23844482612 scopus 로고    scopus 로고
    • Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: Meta-analysis of randomized trials
    • Kastrati A, Dibra A, Eberle S, Mehilli J, Suárez de Lezo J, Goy JJ, Ulm K, Schömig A. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA. 2005;294:819-825.
    • (2005) JAMA , vol.294 , pp. 819-825
    • Kastrati, A.1    Dibra, A.2    Eberle, S.3    Mehilli, J.4    Suárez De Lezo, J.5    Goy, J.J.6    Ulm, K.7    Schömig, A.8
  • 13
    • 33751193459 scopus 로고    scopus 로고
    • Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis
    • Kim YH, Lee BK, Park DW, Park KH, Choi BR, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. Am J Cardiol. 2006;98:1451-1454.
    • (2006) Am J Cardiol , vol.98 , pp. 1451-1454
    • Kim, Y.H.1    Lee, B.K.2    Park, D.W.3    Park, K.H.4    Choi, B.R.5    Lee, C.W.6    Hong, M.K.7    Kim, J.J.8    Park, S.W.9    Park, S.J.10
  • 14
  • 16
    • 77954622024 scopus 로고    scopus 로고
    • Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis
    • Levisay JP, Price MJ, Shaba W, Lee SS, Stinis CP, Miller L, Teirstein PS. Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis. J Invasive Cardiol. 2010;22:216-219.
    • (2010) J Invasive Cardiol , vol.22 , pp. 216-219
    • Levisay, J.P.1    Price, M.J.2    Shaba, W.3    Lee, S.S.4    Stinis, C.P.5    Miller, L.6    Teirstein, P.S.7
  • 17
    • 33750211376 scopus 로고    scopus 로고
    • Predicted mechanisms of resistance to mTOR inhibitors
    • Kurmasheva RT, Huang S, Houghton PJ. Predicted mechanisms of resistance to mTOR inhibitors. Br J Cancer. 2006;95:955-960.
    • (2006) Br J Cancer , vol.95 , pp. 955-960
    • Kurmasheva, R.T.1    Huang, S.2    Houghton, P.J.3
  • 18
    • 33845992883 scopus 로고    scopus 로고
    • Intracoronary radiation therapy for multi-drug resistant in-stent restenosis: Initial clinical experience
    • Price MJ, Giap H, Teirstein PS. Intracoronary radiation therapy for multi-drug resistant in-stent restenosis: initial clinical experience. Catheter Cardiovasc Interv. 2007;69:132-134.
    • (2007) Catheter Cardiovasc Interv , vol.69 , pp. 132-134
    • Price, M.J.1    Giap, H.2    Teirstein, P.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.